Andrew Horwitz's guest appearances

Andrew Horwitz

The Dan Yorke Show

Steve Klamkin

The News with Gene Valicenti

CannMed Coffee Talk

Jasiel Correia

Jonathon Acosta

John Flaherty

Jorge Elorza

Laura Forman

Sheldon Whitehouse

Hilary Levey Friedman

Steven Pare

Roger Williams University

Leonard Lardaro

Brian Daniels

Neil Steinberg

Brett Smiley

Nellie Gorbea

Michael DiBiase

OwlTail

We talk with Dr. Andrew Horwitz Vice President, R&amp;D at Sestina Bio LLC about producing cannabinoids outside the cannabis plant. Previously, Andrew managed the Cannabinoid R&amp;D program at Demetrix, where he helped develop the process for using genetically modified yeast cells to produce cannabinoids. We discuss:The advantages of using yeast cells to produce cannabinoids instead of cannabis and hemp plants How adjusting the precursor molecules that are fed to the yeast cells can produce rare and novel cannabinoidsHow cannabis medicine researchers can use this technology to better understand the entourage effectWhy understanding the way the cannabis plant produces cannabinoids was essential to developing this technology How this technology is received by the cannabis community Thanks to our Sponsor: DemetrixDemetrix is a biotechnology company that believes in the power of science to make the world a better place. The company produces safe, legal, and effective health and wellness products backed by science, including rare, high-purity cannabinoids for pharmaceutical and consumer applications. To learn more, please visit www.demetrixbio.com, and be sure to check out their blog, www.demetrixbio.com/insights. Additional Resources"Developing Fermentation Technology to Produce Specific Cannabinoids for Research and Consumer Use" Andrew Horwitz, PhD, CannMed 2019Sestina Bio, LLC website Demetrix blog Luo, Xiaozhou et al. “Complete biosynthesis of cannabinoids and their unnatural analogues in yeast.” Inscripta Onyx

We talk with Dr. Andrew Horwitz Vice President, R&amp;D at Sestina Bio LLC about producing cannabinoids outside the cannabis plant. Previously, Andrew managed the Cannabinoid R&amp;D program at Demetrix, where he helped develop the process for using genetically modified yeast cells to produce cannabinoids. We discuss: The advantages of using yeast cells to produce cannabinoids instead of cannabis and hemp plants How adjusting the precursor molecules that are fed to the yeast cells can produce rare and novel cannabinoidsHow cannabis medicine researchers can use this technology to better understand the entourage effectWhy understanding the way the cannabis plant produces cannabinoids was essential to developing this technology How this technology is received by the cannabis community  Thanks to our Sponsor: Demetrix Demetrix is a biotechnology company that believes in the power of science to make the world a better place. The company produces safe, legal, and effective health and wellness products backed by science, including rare, high-purity cannabinoids for pharmaceutical and consumer applications. To learn more, please visit <a href="http://www.demetrixbio.com" rel="nofollow" target="_blank">www.demetrixbio.com</a>, and be sure to check out their blog, <a href="http://www.demetrixbio.com/insights" rel="nofollow" target="_blank">www.demetrixbio.com/insights</a>.  Additional Resources "Developing Fermentation Technology to Produce Specific Cannabinoids for Research and Consumer Use" Andrew Horwitz, PhD, CannMed 2019Sestina Bio, LLC website Demetrix blog Luo, Xiaozhou et al. “Complete biosynthesis of cannabinoids and their unnatural analogues in yeast.” Inscripta Onyx

Training Yeast to Produce Cannabinoids with Andrew Horwitz, PhD

Richard Gardner

RWU Professor Andrew Horwitz (Director of the Criminal Defense Clinic) joins the Dan Yorke Show to discuss Mayor Elorza's promise to devote 24/7 protection by Providence PD to sex offender Richard Gardner.

RWU Professor Andrew Horwitz discusses the handling of sex offender Richard Gardner's release from prison by the city of Providence

Prof. Andrew Horwitz at the Roger Williams University School of Law is among more than 1,100 law professors around the country to sign a letter opposing President-elect Donald Trump's choice of Sen. Jeff Sessions (R-Alabama) as United States Attorney General

Law Professor Andrew Horwitz on Sen. Sessions nomination as Attorney General